Filtros de búsqueda

Lista de obras de

A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2)

A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancers

artículo científico publicado en 2020

BRCA Mutations, Homologous DNA Repair Deficiency, Tumor Mutational Burden, and Response to Immune Checkpoint Inhibition in Recurrent Ovarian Cancer

scientific article published on 16 June 2020

Checkpoint inhibition and melanoma: Considerations in treating the older adult

artículo científico publicado en 2017

Clinical Utility of Prospective Molecular Characterization in Advanced Endometrial Cancer

artículo científico publicado en 2018

Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer

scientific article published on 19 November 2019

Combinatorial Cancer Immunotherapies

artículo científico publicado en 2016

Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade

scientific article published on 22 November 2018

Emerging Tissue and Blood-Based Biomarkers that may Predict Response to Immune Checkpoint Inhibition.

artículo científico publicado en 2016

Imaging findings of immune checkpoint inhibitor associated pancreatitis

scientific article published on 29 August 2020

Machine learning-based prediction of microsatellite instability and high tumor mutation burden from contrast-enhanced computed tomography in endometrial cancers

artículo científico publicado en 2020

Measuring Toxic Effects and Time to Treatment Failure for Nivolumab Plus Ipilimumab in Melanoma.

artículo científico publicado en 2017

Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial

artículo científico publicado en 2020

Options for Adjuvant Therapy for Uterine Leiomyosarcoma

artículo científico publicado en 2018

Ovarian cancer mutational processes drive site-specific immune evasion

artículo científico publicado en 2022

Patient-Physician Communication in the 21st Century.

artículo científico publicado en 2016

Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma.

artículo científico publicado en 2018

Phase II study of atezolizumab in combination with bevacizumab in patients with advanced cervical cancer

scientific article published on 01 October 2020

Pretreatment vitamin D level and response to neoadjuvant chemotherapy in women with breast cancer on the I-SPY trial (CALGB 150007/150015/ACRIN6657).

artículo científico publicado en 2014

Prevalence of psychotropic medication use among cosmetic and medical dermatology patients: a comparative study

artículo científico publicado en 2006

Subsequent therapies and survival after immunotherapy in recurrent ovarian cancer

artículo científico publicado en 2019

Thinking Critically About Classifying Adverse Events: Incidence of Pancreatitis in Patients Treated With Nivolumab + Ipilimumab

artículo científico publicado en 2016

Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors: A Review.

artículo científico publicado en 2016

Tumor immunology and cancer immunotherapy: summary of the 2014 SITC primer.

artículo científico publicado en 2015

Utility of serum CA-125 monitoring in patients with ovarian cancer undergoing immune checkpoint inhibitor therapy

artículo científico publicado en 2020

Vitamin d deficiency in postmenopausal breast cancer survivors

artículo científico publicado en 2012

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda